Home›Companies›Biotech & Pharma›Theradaptive

Theradaptive, Inc.

Develops protein-based treatments for people needing bone and tissue repair.

Updated Nov 9, 2026·Latest SEC filing Aug 4, 2026·Suggest an edit

About Theradaptive

Theradaptive is a private company based in Frederick, Maryland. It has reported $36,156,177 raised in one offering on Form D since August 2026. Its chief executive is Luis Alvarez.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 21, 2026Aug 4, 2026$36,156,177of $77.9M target65$556KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Theradaptive's Form D filed Aug 4, 2026.

David Stewart
David Stewart
Chief Operating Officer and director
PZ
Patrick Zhang
Director
Also a director at Perfect Day.
Luis Alvarez
Luis Alvarez
Founder and CEO, director
TM
Ted Meyers
Director
GS

Sources

  1. SECTheradaptive, Inc. filing history
  2. CompanyTheradaptive terms and conditions
  3. CompanyTheradaptive contact
  4. CompanyTheradaptive team
  5. PressATEC and Theradaptive strategic partnership